Get the latest Science News and Discoveries

Stanford Reverses Cognitive Decline in Alzheimer’s With Brain Metabolism Drug

Neuroscientists at Stanford have linked Alzheimer's disease to the disruption of brain metabolism via the kynurenine pathway, which is affected by amyloid plaque and tau proteins. Their research has demonstrated that drugs blocking this pathway can restore cognitive function in Alzheimer's mice b

None

Get the Android app